Top Section/Ad
Top Section/Ad
Most recent
Cypriot night vision goggles manufacturer has benefited from defence industry boom
Capital raise successful amid share volatility
Military goggles maker Theon starts €150m rights issue
More articles/Ad
More articles/Ad
More articles
-
Chinese biopharmaceutical company BeiGene has net $200m from a follow-on public offering of American Depositary Shares (ADSs). -
Last week’s shock US election result caused a rout in emerging markets, with stocks and currencies in southeast Asia among the hardest hit. But unlike in the past, this has not brought equity capital markets activity to a standstill, as share sales in Indonesia, the Philippines and Thailand showed this week. John Loh reports.
-
Bayer, the German life sciences group, picked Tuesday night to launch the first part of its $19bn equity financing for its $66bn takeover of Monsanto. Bayer's deal comes as equity markets are revitalised by the new conviction that Western policy is shifting to reflation.
-
The deal the equity-linked bond market has been awaiting for months has arrived this evening. Bayer, the German life sciences group, has launched a €4bn mandatorily convertible issue as the first part of its $19bn equity financing for its takeover of Monsanto.
-
Real estate investment company MYP is looking to seal a S$188.7m ($133.5m) rights issue in order to help fund its acquisition of the Straits Trading Building in Singapore.
-
Former UBS banker Christopher Fok has resurfaced at CMB International in Hong Kong with a wider role covering both ECM syndicate and origination.
